Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: A prospective study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 12, 2009, Pages 1609-1616

  Rouvas, Alexander ^a,b   Petrou, Petros ^a   Vergados, Ioannis ^a   Pechtasides, Dimitrios ^a   Liarakos, Vasilios ^a   Mitsopoulou, Maria ^a   Ladas, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Gennimatas Hospital ^*  (Greece)

Author keywords

CRVO; Intravitreal injection; Lucentis; Ranibizumab

Indexed keywords

RANIBIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MONOTHERAPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; RETINAL VEIN OCCLUSION; RETREATMENT; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 71449111019     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1138-y     Document Type: Article

References (31)

1. The Central Vein Occlusion Study Group 1995 A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report Ophthalmology 102 1434 1444
2. The Central Vein Occlusion Study Group 1995 Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report Ophthalmology 102 1425 1433
3. JB Jonas 2005 Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases Acta Ophthalmol Scand 83 645 663 10.1111/j.1600-0420.2005.00592.x 16396641 (Pubitemid 41819287)
4. JB Jonas I Akkoyun B Kamppeter I Kreissig RF Degenring 2005 Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion Eur J Ophthalmol 15 751 758 1:STN:280:DC%2BD2MnksVKhug%3D%3D 16329061 (Pubitemid 43074702)
5. NZ Gregori PJ Rosenfeld CA Puliafito HW Flynn Jr JE Lee EC Mavrofrides WE Smiddy TG Murray AM Berrocal IU Scott G Gregori 2006 One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion Retina 26 889 895 10.1097/01.iae.0000237111.82357.30 17031288 (Pubitemid 44547441)
6. MJ Goff JM Jumper SS Yang AD Fu RN Johnson HR McDonald E Ai 2006 Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion Retina 26 896 901 10.1097/01.iae.0000231543. 45699.e1 17031289 (Pubitemid 44547442)
7. PJ Patel I Zaheer N Karia 2008 Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion Eye 22 60 64 10.1038/sj.eye. 6702518 1:CAS:528:DC%2BD1cXnt1CisA%3D%3D 16902493
8. A Ramezani M Entezari S Moradian H Tabatabaei S Kadkhodaei 2006 Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial Graefes Arch Clin Exp Ophthalmol 24 1601 1606 10.1007/s00417-006-0348-9 (Pubitemid 44830818)
9. MM Moschos D Brouzas E Loukianou M Apostolopoulos M Moschos 2007 Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study Doc Ophthalmol 114 1 7 10.1007/s10633-006-9032-y 17109155 (Pubitemid 46206510)
10. LP Aiello RL Avery PG Arrigg BA Keyt HD Jampel ST Shah LR Pasquale H Thieme MA Iwamoto JE Park, et al. 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Eng J Med 331 1480 1487 10.1056/NEJM199412013312203 1:STN:280: DyaK2M%2FlvFamsA%3D%3D (Pubitemid 24356306)
11. RN Frank RH Amin D Eliott JE Puklin GW Abrams 1996 Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes Am J Ophrhalmol 122 393 403 1:STN:280:DyaK28zoslWksA%3D%3D
12. PJ Keck SD Hauser G Krivi K Sanzo T Warren J Feder DT Connolly 1989 Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1309 1312 10.1126/science.2479987 1:CAS:528:DyaK3cXkslGksLc%3D 2479987 (Pubitemid 20066717)
13. DW Leung G Cachianes WJ Kuang DV Goeddel N Ferrara 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1306 1309 10.1126/science.2479986 1:CAS:528:DyaK3cXls1GltLo%3D 2479986
14. DR Senger DT Connolly L Van de Water J Feder HF Dvorak 1990 Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor Cancer Res 50 1774 1778 1:CAS:528:DyaK3cXitFWjtbY%3D 2155059
15. QD Nguyen S Tatlipinar SM Shah JA Haller E Quinlan J Sung I Zimmer-Galler DV Do PA Campochiaro 2006 Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 961 969 10.1016/j.ajo.2006.06.068 1:CAS:528:DC%2BD28Xht12msLfE 17046701 (Pubitemid 44853891)
16. D Iturralde RF Spaide CB Meyerle JM Klancnik LA Yannuzzi YL Fisher J Sorenson JS Slakter KB Freund M Cooney HF Fine 2006 Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 279 284 10.1097/00006982-200603000-00005 16508427 (Pubitemid 44318180)
17. GB Jaissle F Ziemssen K Petermeier P Szurman M Ladewig F Gelisken M Völker FG Holz KU Bartz-Schmidt 2006 Bevacizumab for treatment of macular edema secondary to retinal vein occlusion Ophthalmologe 103 471 475 10.1007/s00347-006-1355-2 1:CAS:528:DC%2BD28XlsV2ksrc%3D 16763863 (Pubitemid 43892185)
18. A Stahl H Agostini LL Hansen N Feltgen 2007 Bevacizumab in retinal vein occlusion-results of a prospective case series Graefes Arch Clin Exp Ophthalmol 245 1429 1436 10.1007/s00417-007-0569-6 1:CAS:528:DC%2BD2sXhtVajs73L 17356824 (Pubitemid 47423323)
19. SG Priglinger AH Wolf TC Kreutzer D Kook A Hofer RW Strauss CS Alge C Kunze C Haritoglou A Kampik 2007 Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial Retina 27 1004 1012 10.1097/IAE.0b013e3180ed458d 18040236 (Pubitemid 350303999)
20. DC Ferrara H Koizumi RF Spaide 2007 Early bevacizumab treatment of central retinal vein occlusion Am J Ophthalmol 14 864 871 10.1016/j.ajo.2007.07. 038 (Pubitemid 350122344)
21. J Hsu RS Kaiser A Sivalingam P Abraham MS Fineman MA Samuel JF Vander CD Regillo AC Ho 2007 Intravitreal bevacizumab (avastin) in central retinal vein occlusion Retina 27 1013 1019 10.1097/IAE.0b013e318050ca7c 18040237 (Pubitemid 350304000)
22. DJ Pieramici M Rabena AA Castellarin M Nasir R See T Norton A Sanchez S Risard RL Avery 2008 Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions Ophthalmology 115 e47 e54 10.1016/j.ophtha.2008.06.021 18708258
23. PA Campochiaro G Hafiz SM Shah QD Nguyen H Ying DV Do E Quinlan I Zimmer-Galler JA Haller SD Solomon JU Sung Y Hadi KA Janjua N Jawed DF Choy JR Arron 2008 Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 791 799 10.1038/mt.2008.10 1:CAS:528:DC%2BD1cXjslCnsLc%3D 18362932
24. RF Spaide LK Chang JM Klancnik LA Yannuzzi J Sorenson JS Slakter KB Freund R Klein 2009 Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion Am J Ophthalmol 147 298 306 10.1016/j.ajo.2008.08.016 1:CAS:528:DC%2BD1MXhtVeisro%3D 18929354
25. DM Brown PK Kaiser M Michels G Soubrane JS Heier RY Kim JP Sy S Schneider ANCHOR Study Group 2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 1432 1444 10.1056/NEJMoa062655 1:CAS:528:DC%2BD28XhtVGgtrrI 17021319 (Pubitemid 44511558)
26. PJ Rosenfeld DM Brown JS Heier DS Boyer PK Kaiser CY Chung RY Kim MARINA Study Group 2006 Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419 1431 10.1056/NEJMoa054481 1:CAS:528:DC%2BD28XhtVGgtr3M 17021318 (Pubitemid 44511557)
27. M El-Ashry V Hegde P James S Pagliarini 2008 Analysis of macular thickness in British population using optical coherence tomography (OCT): an emphasis on interocular symmetry Curr Eye Res 33 8 693 699 18696345
28. BY Kim SD Smith PK Kaiser 2006 Optical coherence tomographic patterns of diabetic macular edema Am J Ophthalmol 142 405 412 10.1016/j.ajo.2006.04.023 16935584 (Pubitemid 44691751)
29. The Central Vein Occlusion Study Group 1997 Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group Arch Ophthalmol 115 486 491
30. Food and Drug Administration (2006). www.fda.gov/cder/foi/label/2006/ 125156lbl.pdf
31. The Central Vein Occlusion Study Group 1993 Baseline and early natural history report. The Central Vein Occlusion Study Arch Ophthalmol. 111 1087 1095